Literature DB >> 18980271

Life expectancy in Gaucher disease type 1.

Neal J Weinreb1, Patrick Deegan, Katherine A Kacena, Pramod Mistry, Gregory M Pastores, Priscilla Velentgas, Stephan vom Dahl.   

Abstract

We estimated life expectancy at birth for Gaucher disease type 1 (GD1) patients by comparing survival data from GD1 patients enrolled in ICGG Gaucher Registry to the U.S. population using standard life table methods. 2,876 GD1 patients had 102 reported deaths in 13,509 person-years of follow-up. Estimated life expectancy at birth was 68 y, compared with 77 y in reference population; splenectomized patients, 64 y; nonsplenectomized, 72 y. Causes of death for 63/102 patients were malignancy (17/63), cardiovascular (11/63), and cerebrovascular (8/63). Estimated life expectancy at birth for GD1 patients was approximately 9 y less than reference population. Malignancies did not contribute to shortened life expectancy. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18980271      PMCID: PMC3743399          DOI: 10.1002/ajh.21305

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  19 in total

1.  Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features.

Authors:  R H Lachmann; D G Wight; D J Lomas; N C Fisher; J P Schofield; E Elias; T M Cox
Journal:  QJM       Date:  2000-04

2.  The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Authors:  J Charrow; H C Andersson; P Kaplan; E H Kolodny; P Mistry; G Pastores; B E Rosenbloom; C R Scott; R S Wappner; N J Weinreb; A Zimran
Journal:  Arch Intern Med       Date:  2000-10-09

3.  Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease.

Authors:  H Ginsberg; G A Grabowski; J C Gibson; R Fagerstrom; J Goldblatt; H S Gilbert; R J Desnick
Journal:  Clin Genet       Date:  1984-08       Impact factor: 4.438

4.  Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease.

Authors:  A Ashkenazi; R Zaizov; Y Matoth
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Authors:  Neal J Weinreb; Joel Charrow; Hans C Andersson; Paige Kaplan; Edwin H Kolodny; Pramod Mistry; Gregory Pastores; Barry E Rosenbloom; C Ronald Scott; Rebecca S Wappner; Ari Zimran
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

6.  A 27-year experience with splenectomy for Gaucher's disease.

Authors:  P R Fleshner; A H Aufses; G A Grabowski; R Elias
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

7.  Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.

Authors:  Pramod K Mistry; Sandra Sirrs; Alicia Chan; Mark R Pritzker; Thomas P Duffy; Marie E Grace; David P Meeker; Martin E Goldman
Journal:  Mol Genet Metab       Date:  2002 Sep-Oct       Impact factor: 4.797

8.  Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients.

Authors:  A Zimran; A Kay; T Gelbart; P Garver; D Thurston; A Saven; E Beutler
Journal:  Medicine (Baltimore)       Date:  1992-11       Impact factor: 1.889

9.  Increased basal glucose production in type 1 Gaucher's disease.

Authors:  E P Corssmit; C E Hollak; E Endert; M H van Oers; H P Sauerwein; J A Romijn
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

10.  Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance.

Authors:  Mirjam Langeveld; Karen J M Ghauharali; Hans P Sauerwein; Mariette T Ackermans; Johanna E M Groener; Carla E M Hollak; Johannes M Aerts; Mireille J Serlie
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

View more
  18 in total

Review 1.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

2.  Letter to the Editor on "Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options".

Authors:  Jennifer Ibrahim; Rebecca Call
Journal:  Hosp Pharm       Date:  2017-10-10

3.  Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.

Authors:  Pramod K Mistry; Neal J Weinreb; Paige Kaplan; J Alexander Cole; Andrea R Gwosdow; Thomas Hangartner
Journal:  Blood Cells Mol Dis       Date:  2010-11-26       Impact factor: 3.039

4.  A reappraisal of Gaucher disease-diagnosis and disease management algorithms.

Authors:  Pramod K Mistry; Maria Domenica Cappellini; Elena Lukina; Hayri Ozsan; Sara Mach Pascual; Hanna Rosenbaum; Maria Helena Solano; Zachary Spigelman; Jesús Villarrubia; Nora Patricia Watman; Gero Massenkeil
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

5.  The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.

Authors:  Barry Rosenbloom; Manisha Balwani; Jeff M Bronstein; Edwin Kolodny; Swati Sathe; Andrea R Gwosdow; John S Taylor; J Alexander Cole; Ari Zimran; Neal J Weinreb
Journal:  Blood Cells Mol Dis       Date:  2010-11-10       Impact factor: 3.039

6.  Gaucher disease: resetting the clinical and scientific agenda.

Authors:  Pramod K Mistry; Neal J Weinreb; Roscoe O Brady; Gregory A Grabowski
Journal:  Am J Hematol       Date:  2009-04       Impact factor: 10.047

7.  Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?

Authors:  Y Ilan
Journal:  Clin Exp Immunol       Date:  2009-09-30       Impact factor: 4.330

Review 8.  Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.

Authors:  Pramod K Mistry; Tamar Taddei; Stephan vom Dahl; Barry E Rosenbloom
Journal:  Crit Rev Oncog       Date:  2013

Review 9.  Gaucher's disease and cancer: a sphingolipid perspective.

Authors:  Brian M Barth; Sriram S Shanmugavelandy; Diana M Tacelosky; Mark Kester; Samy A F Morad; Myles C Cabot
Journal:  Crit Rev Oncog       Date:  2013

10.  Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.

Authors:  Deborah Elstein; Ari Zimran
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.